Industry reports
Editor highlights

Publication dates

Immunotherapy Research Reports, April 2014

You might be interested in: therapeutics, cancer, medical equipment, more »


 

1-10 of 55 reports for Immunotherapy
Analytical Tool - Cancer Immunotherapy

Analytical Tool - Cancer Immunotherapy

  • $ 8 175
  • Industry report
  • March 2014
  • by Bioseeker

... Is a searchable database reflects the most recent advances in the field of immunotherapy drug development in cancer, in order to help you perform your own analysis, go back to the source data for in ...

Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • March 2014
  • by Bioseeker

... immunotherapy in oncology drug pipeline update 2014 cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity ...

Immunotherapy in Oncology: Drug Pathway Analyzer 2014

Immunotherapy in Oncology: Drug Pathway Analyzer 2014

  • $ 3 675
  • Industry report
  • March 2014
  • by Bioseeker

... Specifications3. Compare - you can overlay any pathways with each other and do a comparative analysisyou can interactively analyze any immunotherapy drug-pathway relationship by using up to four ...

Non-small cell lung cancer: Game changing immunotherapies to revolutionise treatment - KOL Insight

Non-small cell lung cancer: Game changing immunotherapies to revolutionise treatment - KOL Insight

  • $ 5 369
  • Industry report
  • March 2014
  • by Firstword Pharma

... immunotherapies, more personalised treatment choices and further drug developments are all set to roll out in the near future. What are the potential blockbusters, who will gain approvals first and what ...

Northwest Biotherapeutics, Inc. (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Northwest Biotherapeutics, Inc. (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

... Company specializing in the discovery, development and commercialization of immunotherapy products that generate and enhance immune system responses to treat cancer. Based on its two basic technology ...

Advaxis, Inc. (Symbol:ADXS) SWOT Analysis, Strategy, Revenues and Profits

Advaxis, Inc. (Symbol:ADXS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2014
  • by Global Data

... Development stage biotechnology company which focuses on discovery, development and commercialization of its proprietary lm- llo immunotherapies. The company is developing products for the treatment of cervical ...

Octapharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Octapharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Clinically develops, produces, and markets human protein therapies from both human plasma and human cell-lines. The company focuses on therapeutic areas such as, haematology and immunotherapy, and intensive ...

ImVisioN Therapeutics AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ImVisioN Therapeutics AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... It develops safe, effective and convenient treatments to treat major allergies. The company applies proprietary intralymphatic immunotherapy, clinically proven to be more convenient means of delivering allergy ...

Dendreon Corporation (DNDN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Dendreon Corporation (DNDN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... And immunotherapy targets such as dn24-02, carbonic anhydrase ix, carcinoembryonic antigen and small molecules like trpm8. The company has research & development and administrative facilities in washington and new ...

Celldex Therapeutics, Inc. (CLDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Celldex Therapeutics, Inc. (CLDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Targeted immunotherapy (pti) platform of cands to treat cancer and other difficult-to-treat diseases. The company's pti platform portfolio comprises of monoclonal antibody programs, apc targeting ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.